Vladimir V. Shuvaev

5.2k total citations · 3 hit papers
74 papers, 3.6k citations indexed

About

Vladimir V. Shuvaev is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Vladimir V. Shuvaev has authored 74 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Physiology and 14 papers in Immunology. Recurrent topics in Vladimir V. Shuvaev's work include Nanoparticle-Based Drug Delivery (12 papers), Nitric Oxide and Endothelin Effects (11 papers) and Cell Adhesion Molecules Research (8 papers). Vladimir V. Shuvaev is often cited by papers focused on Nanoparticle-Based Drug Delivery (12 papers), Nitric Oxide and Endothelin Effects (11 papers) and Cell Adhesion Molecules Research (8 papers). Vladimir V. Shuvaev collaborates with scholars based in United States, France and Japan. Vladimir V. Shuvaev's co-authors include Vladimir R. Muzykantov, Blaine J. Zern, Gérard Siest, Melpo Christofidou‐Solomidou, Jingyan Han, Raisa Y. Kiseleva, Evguenia Arguiri, Silvia Muro, Hamideh Parhiz and Makan Khoshnejad and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Vladimir V. Shuvaev

74 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting vascular (endothelial) dysfunction

2016 387 citations Vladimir V. Shuvaev, Vladimir R. Muzykantov et al. profile →
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

2021 183 citations István Tombácz, Dorottya Laczkó et al. Molecular Therapy profile →
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake

2018 154 citations Hamideh Parhiz, Vladimir V. Shuvaev et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vladimir V. Shuvaev United States	37	1.5k	781	523	519	457	74	3.6k
Yu Ishima Japan	34	2.0k 1.3×	612 0.8×	473 0.9×	602 1.2×	368 0.8×	143	4.0k
Farhad Rezaee Netherlands	27	1.3k 0.9×	850 1.1×	662 1.3×	705 1.4×	243 0.5×	57	3.3k
Florian Krötz Germany	26	1.4k 1.0×	379 0.5×	510 1.0×	354 0.7×	769 1.7×	64	3.9k
Michel Demeule Canada	35	2.2k 1.5×	878 1.1×	406 0.8×	284 0.5×	238 0.5×	87	4.7k
Heather Hatcher United States	18	1.5k 1.0×	324 0.4×	593 1.1×	362 0.7×	301 0.7×	23	3.9k
Thomas Simmet Germany	27	1.8k 1.2×	515 0.7×	382 0.7×	303 0.6×	1.3k 2.8×	46	4.2k
Uwe Michaelis Germany	33	1.7k 1.2×	570 0.7×	428 0.8×	616 1.2×	504 1.1×	62	4.1k
Jing Qin China	33	1.6k 1.1×	943 1.2×	853 1.6×	156 0.3×	895 2.0×	105	4.2k
Qin Lu China	32	1.2k 0.8×	732 0.9×	875 1.7×	113 0.2×	394 0.9×	106	3.0k

Countries citing papers authored by Vladimir V. Shuvaev

Since Specialization

Citations

This map shows the geographic impact of Vladimir V. Shuvaev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir V. Shuvaev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir V. Shuvaev more than expected).

Fields of papers citing papers by Vladimir V. Shuvaev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir V. Shuvaev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir V. Shuvaev. The network helps show where Vladimir V. Shuvaev may publish in the future.

Co-authorship network of co-authors of Vladimir V. Shuvaev

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir V. Shuvaev. A scholar is included among the top collaborators of Vladimir V. Shuvaev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir V. Shuvaev. Vladimir V. Shuvaev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shuvaev, Vladimir V., et al.. (2024). Engineered Dual Antioxidant Enzyme Complexes Targeting ICAM-1 on Brain Endothelium Reduce Brain Injury-Associated Neuroinflammation. Bioengineering. 11(3). 200–200. 3 indexed citations

Parhiz, Hamideh, Vladimir V. Shuvaev, Qin Li, et al.. (2024). Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system. Molecular Therapy — Nucleic Acids. 35(2). 102175–102175. 11 indexed citations

Ferguson, Laura T., Jacob W. Myerson, Jichuan Wu, et al.. (2023). Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases. SHILAP Revista de lepidopterología. 3(3). 2200106–2200106. 19 indexed citations

Ferguson, Laura T., Jacob W. Myerson, Jichuan Wu, et al.. (2023). Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases. Advanced NanoBiomed Research. 3(3). 10 indexed citations

Tombácz, István, Dorottya Laczkó, Hamna Shahnawaz, et al.. (2021). Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs. Molecular Therapy. 29(11). 3293–3304. 183 indexed citations breakdown →

Lutton, Evan M., S. Katie Farney, Allison M. Andrews, et al.. (2019). Endothelial Targeted Strategies to Combat Oxidative Stress: Improving Outcomes in Traumatic Brain Injury. Frontiers in Neurology. 10. 582–582. 31 indexed citations

Khoshnejad, Makan, Hamideh Parhiz, Vladimir V. Shuvaev, Ivan J. Dmochowski, & Vladimir R. Muzykantov. (2018). Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting. Journal of Controlled Release. 282. 13–24. 114 indexed citations

Parhiz, Hamideh, Vladimir V. Shuvaev, Norbert Pardi, et al.. (2018). PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake. Journal of Controlled Release. 291. 106–115. 154 indexed citations breakdown →

Goitre, Luca, Peter V. DiStefano, Andrea Moglia, et al.. (2017). Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium. Scientific Reports. 7(1). 8296–8296. 48 indexed citations

10.

Kiseleva, Raisa Y., Colin F. Greineder, Carlos H. Villa, et al.. (2017). Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1. PLoS ONE. 12(1). e0169537–e0169537. 11 indexed citations

11.

Myerson, Jacob W., et al.. (2017). Fluorescence Microscopy Imaging Calibration for Quantifying Nanocarrier Binding to Cells During Shear Flow Exposure. Journal of Biomedical Nanotechnology. 13(6). 737–745. 6 indexed citations

12.

Lutton, Evan M., Roshanak Razmpour, Allison M. Andrews, et al.. (2017). Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury. Scientific Reports. 7(1). 3846–3846. 61 indexed citations

13.

Shuvaev, Vladimir V., et al.. (2015). Targeted endothelial nanomedicine for common acute pathological conditions. Journal of Controlled Release. 219. 576–595. 42 indexed citations

14.

Ferrer, M. Carme Coll, Vladimir V. Shuvaev, Blaine J. Zern, et al.. (2014). ICAM-1 Targeted Nanogels Loaded with Dexamethasone Alleviate Pulmonary Inflammation. PLoS ONE. 9(7). e102329–e102329. 73 indexed citations

15.

Hood, Elizabeth D., Colin F. Greineder, Chandra Dodia, et al.. (2012). Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo. Journal of Controlled Release. 163(2). 161–169. 64 indexed citations

16.

Shuvaev, Vladimir V., Melpo Christofidou‐Solomidou, Faiz Y. Bhora, et al.. (2009). Targeted Detoxification of Selected Reactive Oxygen Species in the Vascular Endothelium. Journal of Pharmacology and Experimental Therapeutics. 331(2). 404–411. 64 indexed citations

17.

Laffont, Isabelle, Vladimir V. Shuvaev, Olivier Briand, et al.. (2002). Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1583(1). 99–107. 19 indexed citations

18.

Shuvaev, Vladimir V., Junichi Fujii, Yoshimi Kawasaki, et al.. (1999). Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1454(3). 296–308. 29 indexed citations

19.

Schiele, F, et al.. (1999). Capillary electrophoretic analysis of recombinant human apolipoprotein E. Journal of Chromatography A. 853(1-2). 237–241. 5 indexed citations

20.

Dergunov, Alexander D., Vladimir V. Shuvaev, & Perova Nv. (1990). [Dynamic behavior of apoproteins of human plasma very low density lipoproteins and lipolysis regulation].. PubMed. 55(1). 134–46. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact